
Please try another search
Breaking News
Vir Biotechnology, Inc. (NASDAQ:VIR) was a big mover last session, as the company saw its shares rise nearly 13% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $16.26 –$60.20 in the past one-month time frame, witnessed a sharp increase yesterday.
The upmove came after the company announced a research collaboration agreement with the National Institutes of Health Vaccine Research Center to develop antibodies against coronaviruses, including SARS-CoV-2.
The company has seen no changes when it comes to estimate revision over the past few weeks, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Vir currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Vir Biotechnology, Inc. Price
Investors interested in the Medical - Biomedical and Genetics industry may consider Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) , which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Is VIR going up? Or down? Predict to see what others think:Up or Down
The Hottest Tech Mega-Trend of All
Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>
New tariffs stoke inflation fears and rattle markets. With recession risks rising, defensive stocks look more appealing. InvestingPro spots three undervalued picks with...
The market for 3M (NYSE:MMM) stock is on fire, with shares rising by 7% in the final week of February and 65% in the preceding 12 months, and there is more upside ahead. The...
There are times when markets are driven by fear, keeping most investors away from what could be a life-changing trade or investment only because the rest of the media and...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.